OPAZZUS Trademark

Trademark Overview


On Tuesday, July 19, 2022, a trademark application was filed for OPAZZUS with the United States Patent and Trademark Office. The USPTO has given the OPAZZUS trademark a serial number of 97509992. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, May 17, 2024. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The OPAZZUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of pain
opazzus

General Information


Serial Number97509992
Word MarkOPAZZUS
Filing DateTuesday, July 19, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, May 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Friday, July 22, 2022NEW APPLICATION ENTERED
Tuesday, August 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 6, 2023ASSIGNED TO EXAMINER
Tuesday, March 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, November 18, 2023SOU EXTENSION 1 FILED
Saturday, November 18, 2023SOU EXTENSION 1 GRANTED
Tuesday, November 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, November 18, 2023SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024SOU EXTENSION 2 GRANTED
Friday, May 17, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 17, 2024SOU EXTENSION 2 FILED